Distal Versus Conventional Radial Access for Coronary Angiography and Intervention: The DISCO RADIAL Trial
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, randomizované kontrolované studie, práce podpořená grantem
PubMed
35595673
DOI
10.1016/j.jcin.2022.04.032
PII: S1936-8798(22)00897-4
Knihovny.cz E-zdroje
- Klíčová slova
- distal radial access, percutaneous coronary intervention, radial artery occlusion, randomized trial, transradial access,
- MeSH
- arteria radialis diagnostické zobrazování MeSH
- arteriální okluzní nemoci * MeSH
- koronární angiografie škodlivé účinky metody MeSH
- koronární angioplastika * škodlivé účinky metody MeSH
- lidé MeSH
- periferní katetrizace * škodlivé účinky metody MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
BACKGROUND: Currently, transradial access (TRA) is the recommended access for coronary procedures because of increased safety, with radial artery occlusion (RAO) being its most frequent complication, which will increasingly affect patients undergoing multiple procedures during their lifetimes. Recently, distal radial access (DRA) has emerged as a promising alternative access to minimize RAO risk. A large-scale, international, randomized trial comparing RAO with TRA and DRA is lacking. OBJECTIVES: The aim of this study was to assess the superiority of DRA compared with conventional TRA with respect to forearm RAO. METHODS: DISCO RADIAL (Distal vs Conventional Radial Access) was an international, multicenter, randomized controlled trial in which patients with indications for percutaneous coronary procedure using a 6-F Slender sheath were randomized to DRA or TRA with systematic implementation of best practices to reduce RAO. The primary endpoint was the incidence of forearm RAO assessed by vascular ultrasound at discharge. Secondary endpoints include crossover, hemostasis time, and access site-related complications. RESULTS: Overall, 657 patients underwent TRA, and 650 patients underwent DRA. Forearm RAO did not differ between groups (0.91% vs 0.31%; P = 0.29). Patent hemostasis was achieved in 94.4% of TRA patients. Crossover rates were higher with DRA (3.5% vs 7.4%; P = 0.002), and median hemostasis time was shorter (180 vs 153 minutes; P < 0.001). Radial artery spasm occurred more with DRA (2.7% vs 5.4%; P = 0.015). Overall bleeding events and vascular complications did not differ between groups. CONCLUSIONS: With the implementation of a rigorous hemostasis protocol, DRA and TRA have equally low RAO rates. DRA is associated with a higher crossover rate but a shorter hemostasis time.
Cardio Center IRCCS Humanitas Research Hospital Rozzano Milan Italy
Department of Cardiology Centre Hospitalier Universitaire de Charleroi Charleroi Belgium
Department of Cardiology Geneva University Hospital Geneva Switzerland
Department of Cardiology Isala Heart Center Zwolle the Netherlands
Department of Cardiology Jolimont Hospital La Louvière Belgium
Department of Cardiology Shonan Kamakura General Hospital Kanagawa Japan
Department of Cardiology Universitair Ziekenhuis Brussel Vrije Universiteit Brussel Brussels Belgium
Division of Cardiology Cliniques Universitaires Saint Luc Brussels Belgium
Division of Cardiology Sant'Eugenio Hospital Rome Italy
Interventional Cardiology Department University Clinic of Cardiology Skopje North Macedonia
Citace poskytuje Crossref.org